Table 2 Results of the critical appraisal of included studies
Study | Representativeness of sample | Ascertainment of alcohol consumption | Ascertainment of AI medications (classified) | Ascertainment of AI medications (measured) | Assessment of the outcome (concurrent use) | Study total: |
|---|---|---|---|---|---|---|
a) Cross Sectional Studies Outcome of Interest Concurrent use of alcohol and medications: | ||||||
Adams et al. 1995 [18] | ++ | + | +++ | |||
Aira et al. 2005 [19] | + | ++ | ++ | +++++ | ||
Breslow et al. 2015 [20] | ++ | ++ | ++ | ++ | ++ | ++++++++++ |
Cousins et al. 2014 [21] | ++ | ++ | ++ | ++ | ++ | ++++++++++ |
Del Rio et al. 1996 [23] | + | ++ | +++ | |||
Del Rio et al. 2002 [22] | + | ++ | ++ | +++++ | ||
Du et al. 2008 [14] | + | ++ | ++ | ++ | ++ | +++++++++ |
Forster et al. 1995 [24] | ++ | + | ++ | +++++ | ||
Ilomaki et al. 2008 [25] | + | ++ | ++ | ++ | ++ | +++++++++ |
Ilomaki et al. 2013 [26] | + | ++ | ++ | ++ | ++ | +++++++++ |
Immonen et al. 2012 [27] | ++ | + | ++ | +++++ | ||
John et al. 2007 [28] | + | + | ++ | ++ | ++++++ | |
Lagnaoui et al. 2001 [36] | ++ | ++ | ||||
Onder et al. 2002 [29] | + | + | ||||
Pringle et al. 2005 [30] | + | ++ | ++ | +++++ | ||
Sheahan et al. 1995 [32] | + | ++ | ++ | +++++ | ||
Qato et al. 2015 [31] | + | ++ | ++ | ++ | ++ | +++++++++ |
Swift et al. 2007 [33] | + | + | ||||
Veldhuizen et al. 2009 [34] | + | ++ | ++ | ++ | ++ | +++++++++ |
Wong et al. 2016 [35] | ||||||